2Asadullah K, Sabat R, Wiese A, et al. Interleukin - 10 in cutaneous disorders implications for pathophysiological importance and therapeutic use. Arch Dermatol Res 1999;291:628 - 636.
3Fierlbeck G, Rasser G, Muller C. Psoriasis induced at the injection site of recombinant interferon gamma. Arch Dermatol Res 1990; 126;351 - 355.
6Ozawa M, Ferenczi K, Kikuchi T, et al. 312 - nanometer ultraviolet B light ( narrow - band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189:711 - 718.
8Tjioe M, Smits T, van de Kerkhof PC, et al. The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol 2003 ; 12 : 729 - 733.
9Krutmann J, Morita A. Mechanisms of uhraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc 1999;4:70- 72.
10Redondo P, Garcia- Forcillas J, Okroujnov I, et al. Alpha- MSH regulates interleukin- 10 expression by human keratinocytes. Arch Dermatol Res 1998;290:425- 428.
7Mallon E, Newson R, Bunker C B.HLA-Cw6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies[J]. J Invest Dermatol,1999; 113(4): 693
8Murakata H,Harabuchi Y,Kataura A et al.Increased interleukin-6, interferon-gamma and tumour necrosis factor-alpha production by tonsillar mononuclear cells stimulated with alpha-streptococci in patients with pustulosis palmaris et plantaris[J]. Acta Otolaryngol,1999;119(3):384
9Chu A, Hong K, Berg E L et al.Tissue specificity of E- and P-selectin ligands in Th1-mediated chronic inflammation[J]. J Immunol,1999;163(9):5086
10Park W, Weyand C M, Schmidt D et al.Costimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells[J]. Eur J Immunol,1997;27(5):1082
